Cloxotestosterone acetate (INN ; brand name Caprosem), also known as testosterone 17β-chloral hemiacetal O-acetate, is a synthetic, injected anabolic–androgenic steroid (AAS) and an androgen ether and ester – specifically, the O-acetate ester of cloxotestosterone, the 17β-trichloro hemiacetal ether of testosterone.[1] It is administered via intramuscular injection, as a 100 mg, 2 mL aqueous suspension and lasts 4 to 6 weeks with a single administration.[2][unreliable source?] The drug was first marketed in the early 1960s.[2]
Clinical data | |
---|---|
Trade names | Caprosem |
Other names | Testosterone 17β-chloral hemiacetal O-acetate; 17β-(1-(Acetyloxy)-2,2,2-trichloroethoxy)androst-4-en-3-one |
Routes of administration | Intramuscular injection |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H31Cl3O4 |
Molar mass | 477.85 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 641–. ISBN 978-1-4757-2085-3.
- ^ a b "Advertisements". Proceedings of the Royal Society of Medicine. 56 (1). 1963. PMC 1896961.[verification needed]